Marshfield Associates lowered its holdings in shares of Waters Corporation (NYSE:WAT) by 2.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,200 shares of the medical instruments supplier’s stock after selling 2,075 shares during the quarter. Waters Corporation accounts for about 1.4% of Marshfield Associates’ portfolio, making the stock its 18th biggest position. Marshfield Associates owned about 0.13% of Waters Corporation worth $18,972,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in WAT. Oppenheimer Asset Management Inc. raised its position in shares of Waters Corporation by 0.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 2 shares during the period. Watermark Asset Management Inc. acquired a new stake in shares of Waters Corporation during the first quarter worth about $106,000. ETF Managers Group LLC acquired a new stake in shares of Waters Corporation during the second quarter worth about $106,000. Intellectus Partners LLC raised its position in shares of Waters Corporation by 4.9% during the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 31 shares during the period. Finally, First Manhattan Co. acquired a new stake in shares of Waters Corporation during the second quarter worth about $130,000. 91.00% of the stock is currently owned by institutional investors.
In other news, SVP Rohit Khanna sold 18,400 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the completion of the sale, the senior vice president now directly owns 22,477 shares of the company’s stock, valued at $4,175,777.06. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Christopher A. Kuebler sold 3,500 shares of the stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the completion of the sale, the director now directly owns 17,849 shares of the company’s stock, valued at $3,206,929.83. The disclosure for this sale can be found here. Corporate insiders own 5.07% of the company’s stock.
Shares of Waters Corporation (NYSE:WAT) traded up 0.18% during midday trading on Friday, reaching $186.14. The company had a trading volume of 56,872 shares. Waters Corporation has a 12-month low of $133.35 and a 12-month high of $190.39. The stock has a market capitalization of $14.86 billion, a PE ratio of 28.05 and a beta of 0.81. The stock’s 50 day moving average is $183.65 and its 200-day moving average is $177.21.
Waters Corporation (NYSE:WAT) last issued its quarterly earnings data on Tuesday, July 25th. The medical instruments supplier reported $1.76 EPS for the quarter, topping the consensus estimate of $1.71 by $0.05. The firm had revenue of $558.30 million during the quarter, compared to the consensus estimate of $553.22 million. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.58 earnings per share. On average, equities research analysts predict that Waters Corporation will post $7.39 earnings per share for the current fiscal year.
A number of equities research analysts have recently commented on WAT shares. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price target on the stock in a research report on Thursday, July 13th. BidaskClub lowered Waters Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Jefferies Group LLC reaffirmed a “hold” rating and set a $175.00 price target on shares of Waters Corporation in a research report on Thursday, July 27th. Deutsche Bank AG lowered Waters Corporation from a “buy” rating to a “hold” rating and raised their price target for the stock from $183.00 to $194.00 in a research report on Monday, July 10th. Finally, Cowen and Company reaffirmed a “hold” rating and set a $190.00 price target on shares of Waters Corporation in a research report on Friday, July 14th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Waters Corporation presently has a consensus rating of “Hold” and an average target price of $186.25.
Waters Corporation Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.